John Plukker

John Plukker is a Professor of Surgical Oncology at the University of Groningen, Faculty of Medical Sciences. His research focuses on gastrointestinal oncology, particularly esophageal and stomach cancers, as well as endocrine head and neck surgery. He has contributed to advancements in neoadjuvant chemoradiotherapy, biomarker discovery, and surgical outcomes. His work spans over 276 publications, emphasizing predictive biomarkers, radiomics, and clinical trial outcomes. Plukker has supervised multiple PhD students and contributed to clinical guidelines for thyroid and esophageal cancers. He is affiliated with the University Medical Center Groningen and holds roles on medical committees such as CvT/IKNL and METC UMCG.

Research interests include tumor microenvironment analysis, residual cancer detection via PET radiomics, and personalized therapy strategies. His studies address treatment optimization for esophageal cancer patients, including extended CROSS criteria and motion analysis for radiotherapy precision. Collaborations span oncology, radiology, and surgical disciplines.

Key contributions include a 10-year CROSS trial analysis, risk calculators for lymph node metastases, and thyroid organoid models for regenerative medicine. His work bridges clinical practice and translational research, aiming to improve survival and quality of life for cancer patients.